ESMO 2017 | Biosimilars: what oncologists need to know

Fernando de Mora Perez

Fernando de Mora Perez, PhD, MBA, from the Autonomous University of Barcelona, Barcelona, Spain, tells us why oncologists need further education on biosimilars. He discusses the reasons why they should be confident that these medicines will be just as safe and effective as the originator brands. This video was recorded at the European Society for Medical Oncology (ESMO) 2017 in Madrid, Spain.

Share this video  
8th September 2017